MALVERN, Pa., July 15, 2024 /PRNewswire/ — Endo, Inc. (OTCQX: NDOI) announced today the launch of tiopronin delayed-release tablets, a generic version of Travere Therapeutics’ THIOLA EC®. “We’re proud to provide high-quality, affordable choices to healthcare providers and their…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.